Stock Ticker

  • Loading stock data...

Cornerstone Therapeutics Inc. (NASDAQ:CRTX) enters into an agreement with Digestive Care

Boston, MA 06/06/2013 (wallstreetpr) – The shares of Cornerstone Therapeutics Inc. (NASDAQ:CRTX) had surged by 10.14 percent to close at $9.99 per share for the end of last trading session on Wednesday. The shares of the pharmaceutical company had been trading in the range of $8.99 to $10.23 per share during the day, before closing at $0.92 per share higher than the previous closing price. This recent surge in share prices of Cornerstone Therapeutics Inc. (NASDAQ:CRTX) had led the company to hit new 52 week high price level at $10.23 per share and the 52 week low price level of the company is at $3.10 per share.

Cornerstone Therapeutics Inc. (NASDAQ:CRTX) is a specialty pharmaceutical company with primary focus on the development and commercialization of products for the hospital, respiratory and related specialty products. The product candidates of the company include CUROSURF, ZYFLO CR, FACTIVE and SPECTRACEF.

Cornerstone Therapeutics Inc. (NASDAQ:CRTX) had recently entered into an agreement with Digestive Care Inc. to acquire exclusive rights for marketing PERTZYE (R) in the United States. The drug is used in the treatment of Exocrine pancreatic insufficiency due to cystic fibrosis.

Cornerstone Therapeutics Inc. (NASDAQ:CRTX), the specialty pharmaceutical had witnessed a heavy trading volume with nearly 240,280 shares being exchanged hands on the last trading session of Wednesday, while the average trading volume of the company is at 83,185 shares per day.

Cornerstone Therapeutics Inc. (NASDAQ:CRTX) presently holds 26.80 million shares outstanding in the market with an institutional ownership in the company at 13 percent of its holdings

Published by Donna Fago

I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at recently due to my passion for the markets.

  • Recent Stories

    SignUp Now For Our Featured Newsletter

    Sign Up To Get Our Latest Stocks Alerts